Quantcast

Latest Steroids Stories

2014-06-05 13:12:11

University of Pennsylvania School of Medicine Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine. Daniel J. Rader, MD, chair of the Department of Genetics and associate...

2014-06-01 12:20:22

Data From Phase 3 TESLA Study in Patients With Homozygous Familial Hypercholesterolemia (HoFH) and Phase 2/3 TAUSSIG Study in Patients With Severe Familial Hypercholesterolemia Presented in Late-Breaking Session at EAS 2014 THOUSAND OAKS, Calif., June 1, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase 3 TESLA study evaluating its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), in patients with homozygous...

2014-05-21 23:08:59

Pittsburgh-based InventHelp attempts to submit an invention, Cholesterol Reader, to companies for review. Pittsburgh, PA (PRWEB) May 21, 2014 "Everyone I know talks about their cholesterol," said an inventor from Oakland Park, Fla. "All of us have to go to the doctor whenever we want our cholesterol levels checked. This is inconvenient and expensive, which is why I came up with a way to test your cholesterol at home." He developed the Cholesterol Reader to effectively...

infertility and high cholesterol
2014-05-21 05:21:38

redOrbit Staff & Wire Reports - Your Universe Online Couples who are having trouble conceiving might want to have their cholesterol levels checked, according to new research published online Tuesday by The Journal of Clinical Endocrinology and Metabolism. According to the study authors, high cholesterol could impair fertility, and couples in which each partner had elevated levels took the longest time to conceive. Furthermore, cases in which the woman had a high cholesterol level...

2014-04-02 08:33:03

Researchers Continue to Reveal Benefits to Consuming Anthocyanin-Rich Foods like Strawberries WATSONVILLE, Calif., April 2, 2014 /PRNewswire-USNewswire/ -- According to new published research in the Journal of Nutrition, consumption of anthocyanin-rich foods such as strawberries may play an important role in lowering cholesterol and other risk factors for cardiovascular disease. To evaluate the effects of strawberries on cardiovascular risk factors, researchers at Oklahoma State University...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...

2014-03-28 08:26:53

U.S. Healthcare Professionals Now Can Perform Lab-Accurate Lipid and Liver Diagnostics with a simple fingerstick using the Piccolo® Blood Chemistry Analyzer. UNION CITY, Calif., March 28, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for...

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...

2014-03-07 16:22:46

ALEXANDRIA, Va., March 7, 2014 /PRNewswire/ -- A new study just released in the American Journal of Clinical Nutrition found that different flavors of peanuts - salted, spicy, honey-roasted, or unsalted - result in positive health benefits. The study, "A Randomized Trial on the Effects of Flavorings on the Health Benefits of Daily Peanut Consumption," was conducted at Purdue University and included over 150 men and women who incorporated peanuts into their daily diet for 12 weeks....


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related